Document is current
Any future updates will be listed below
-
Authors
dos Santos, Gilson Goncalves
Jiménez-Andrade, Juan Miguel
Muñoz-Islas, Enriqueta
Candanedo-Quiroz, Mariana E.
Cardenas, Andrea Gonzalez
Drummond, Bronwen
Pham, Peter
Stilson, Gwendalynn
Hsu, Chao-Chin
Delay, Lauriane
Navia-Pelaez, Juliana M.
Lemes, Julia Paes
Miller, Yury I.
Yaksh, Tony L.
Corr, Maripat
-
Funding
Funding for this research was provided by:
NIH/NINDS (R01 NS099338, R01 NS099338, NS132483, NS132483, NS132483, NS132483, R01 NS099338)
National Institute of Neurological Disorders and Stroke (R01 NS099338, R01 NS099338, R01 NS099338)
National Council of Science and Technology Foundation of Mexico (CONACYT-CB2017-2018/A1-S-27869)
- License Information
-
More Information
Article History
Received: 6 July 2024
Accepted: 23 October 2024
First Online: 18 December 2024
Declarations
:
: Animal experiments were approved by the UCSD Institutional Animal Care and Use Committee (IACUC). No human subjects or human material were included in these studies.
: Not applicable.
: TLY and YIM are inventors listed in patent applications related to the topic of this paper and scientific co-founders of Raft Pharmaceuticals LLC. The terms of this arrangement have been reviewed and approved by the University of California San Diego, in accordance with its conflict-of-interest policies. Other authors declare that they have no competing interests.
